1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Brain Cancer (Glioblastoma Multiforme): Disease and Pipeline Analysis

Brain Cancer (Glioblastoma Multiforme): Disease and Pipeline Analysis

  • February 2014
  • -
  • Industry Standard Research
  • -
  • 59 pages

Summary

Table of Contents

This report offers a unique therapeutic assessment and in-depth market and pipeline analysis, providing a view of the glioblastoma multiforme (brain cancer) market not available elsewhere. This reports gives an overview of the current and future brain cancer clinical development market, the activities of the key market players, and outlines trial and commercial regulatory environments.

What you will learn in this report:
How you can use this report:
- Identify and enhance commercial and development opportunities with an in-depth and current analysis of the global glioblastoma multiforme market
- Understand how products currently in development could impact this market and how large and small pharma is involved
- Assess the competition with an analysis and summary of companies playing in this space
- Brand Managers
- Portfolio Managers
- Research & Development
- Managed Markets

Companies Included:
Descriptions of product names, mechanism of actions (MOA), and highest development phase for the following companies:
- AbbVie
- Actelion Pharma
- Activartis
- Aduro Biotech
- Advantagene
- Agenus
- Amgen
- Angiochem
- Antisense Pharma
- Apogenix
- Archer Biosciences
- Arno Therapeutics
- Ascenta Therapeutics
- AstraZeneca (MedImmune)
- BristolMeyersSquibb
- Cell Therapeutics
- Celldex Therapeutics
- CytoVac A/S
- DelMar Pharma
- Dendreon
- Diffusion Pharma
- DNAtrix Inc
- Eisai
- Eli Lilly (Imclone)
- EMD Serono
- EnGenIC
- Erimos Pharma
- Genentech
- GW Pharma
- Immatics Biotechnologies
- ImmunoCellular Therapeutics
- Innocell Corp
- Lentigen
- Merck (Schering-Plough)
- Merck KGaA
- Northwest Biotherapeutics
- Novartis
- NovaRx
- Oncolytics Biotech
- Oncothyreon
- Oncovir Inc.
- Peregrine Pharma
- Plexxikon
- Roche
- Sangamo Biosciences
- Sanofi (Exelixis)
- Sanofi Aventis
- StemLine Therapeutics
- Tau Therapeutics
- Thallion Pharma
- Threshold Pharma
- To-BBB technologies BV
- Tocagen
- TVAX Biomedical
- Valycyte
- VBL Therapeutics
- Visualase Inc.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Glioblastoma Multiforme-Market Insights, Epidemiology and Market Forecast-2023

Glioblastoma Multiforme-Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Glioblastoma Multiforme - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...

Brain Cancer Treatment Drugs Markets in China

Brain Cancer Treatment Drugs Markets in China

  • $ 4000
  • Industry report
  • April 2017
  • by Asia Market Information & Development Company

China’s demand for Brain Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high ...

Glioblastoma multiforme (GBM) - Epidemiology Forecast To 2023

Glioblastoma multiforme (GBM) - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Glioblastoma multiforme (GBM) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Glioblastoma multiforme (GBM) in seven major markets (US, France, Germany, ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in Australia

  • April 2017
    98 pages
  • Cancer  

    Smoking Statist...  

  • Australia  

View report >

Cancer Statistics in the US

  • March 2017
    22 pages
  • Cancer  

  • United States  

    North America  

View report >

Lymphoma Statistics in Germany

  • March 2017
    167 pages
  • Lymphoma  

    Cancer  

    Leukemia  

  • Germany  

    Europe  

    United States  

View report >

Cancer Statistics

6 months ago

Related Market Segments :

Brain Cancer

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.